Cite
HARVARD Citation
Papadopoulos, K. et al. (n.d.). Early evidence of dose-dependent pharmacodynamic activity following treatment with SY-5609, a highly selective and potent oral CDK7 inhibitor, in patients with advanced solid tumors. European journal of cancer. pp. S50-. [Online].